NZeno
Latest round
- Seed
Last raised
- Jul 2017
Total raised
- Undisclosed
Investors
- 3
About NZeno
NZeno is focused on the production of genetically modified pigs whose kidneys can be used for human transplantation. The company was founded in New Zealand and has not undergone any significant pivots in its business strategy.NZeno specializes in the development and supply of genetically modified pigs that produce kidneys suitable for human transplantation. By employing advanced gene editing technology, NZeno modifies high health status New Zealand pigs to inactivate specific genes responsible for immune rejection, allowing their kidneys to be compatible with human recipients. The core product offering consists of these safe pig kidneys, which aim to address the critical shortage of human kidney donors faced by individuals suffering from End Stage Renal Disease (ESRD). The primary end users of these products are patients in need of kidney transplants, along with healthcare providers and transplant centers across regions where organ shortages are prevalent.NZeno's revenue model is structured around the sale and potential licensing of its genetically modified pig kidneys to healthcare providers and transplant facilities. The transactions typically involve direct partnerships with hospitals and transplant centers, where NZeno supplies the kidneys as a solution to meet increasing demand from patients requiring transplants. While specific pricing plans are not disclosed, the nature of the transactions suggests a potential blend of upfront payments for the kidneys and ongoing agreements based on usage or patient outcomes.NZeno plans to launch new products that enhance the capabilities of their genetically modified kidneys, with expected releases in the next 12 to 18 months. The company is also targeting expansion into key markets in North America and Europe by the end of 2024, as these regions face significant organ shortages.
Who invested in NZeno
3 investors across 1 round
See all investors in NZeno
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 1, 2017
Amount
Undisclosed
Investors
Questions about NZeno
Who invested in NZeno?
NZeno has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NZeno raised?
NZeno has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NZeno last raise money?
NZeno's most recent round on record is a Seed, in Jul 2017.
What does NZeno do?
NZeno is focused on the production of genetically modified pigs whose kidneys can be used for human transplantation.
Where is NZeno headquartered?
NZeno is headquartered in Auckland, New Zealand.
Which VCs invest in companies like NZeno?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back biotechnology companies at NZeno's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like NZeno? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.